Fortis Healthcare acquires Fortis Trademark for Rs 200 crore
New Delhi: Fortis Healthcare announced on Wednesday that it has successfully acquired the Fortis trademark through a public auction with a bid of Rs 200 crore.
As intimated on October 30, 2024, by way of order dated October 29, 2024, the Hon'ble Delhi High Court had ordered for the sale of the 'Fortis' trademarks and allied marks by way of public auction, as, pursuant to the Hon'ble Supreme Court of India's judgment dated September 22, 2022, the healthcare provider said in a regulatory filing.
The Fortis Marks, which were held by certain entities owned and controlled by the erstwhile promoters of the company, were attached and made available to the Hon'ble Delhi High Court for satisfaction of a decree in favour of Daiichi Sankyo Company Limited, it added, news agency PTI reported.
Also Read:Fortis acquires Shrimann Superspecialty Hospital in Jalandhar for Rs 462 crore
Pursuant to the aforesaid order, a public auction was conducted, wherein the company emerged as the successful bidder for the Fortis Marks basis its bid of Rs 200 crore, Fortis Healthcare said.
"By way of its judgment dated March 25, 2025, the Hon'ble Delhi High Court has confirmed the sale of the Fortis Marks and all attendant rights and liabilities in favour of the company pursuant to the public auction process," it added.
Medical Dialogues had earlier reported that Fortis Healthcare Limited (''FHL'' or ''Fortis'' or the ''Company''), amongst India's leading healthcare delivery companies announced that it has signed definitive agreements for the acquisition of Shrimann Superspecialty Hospital in Jalandhar, Punjab (''Shrimann Hospital'') from inter alia Shriman Enterprises (a partnership firm) by way of a slump sale. The acquisition would be undertaken by FHL’s wholly-owned subsidiary Fortis Hospotel Limited (FHTL) and is subject to FHL shareholder approval.
Also Read:IHH Healthcare Seeks USD 1.7 Billion from Daiichi Sankyo Over Fortis Deal Disruption
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.